These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 24436515)

  • 1. Intra-arterial liver-directed therapies for neuroendocrine hepatic metastases.
    Gupta S
    Semin Intervent Radiol; 2013 Mar; 30(1):28-38. PubMed ID: 24436515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transarterial liver-directed therapies of neuroendocrine hepatic metastases.
    Nazario J; Gupta S
    Semin Oncol; 2010 Apr; 37(2):118-26. PubMed ID: 20494704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-Pharmacological Therapeutic Options for Liver Metastases in Advanced Neuroendocrine Tumors.
    Dermine S; Palmieri LJ; Lavolé J; Barré A; Dohan A; Abou Ali E; Cottereau AS; Gaujoux S; Brezault C; Chaussade S; Coriat R
    J Clin Med; 2019 Nov; 8(11):. PubMed ID: 31703375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic intra-arterial therapies in metastatic neuroendocrine tumors: lessons from clinical practice.
    Grozinsky-Glasberg S; Kaltsas G; Kaltsatou M; Lev-Cohain N; Klimov A; Vergadis V; Uri I; Bloom AI; Gross DJ
    Endocrine; 2018 Jun; 60(3):499-509. PubMed ID: 29383678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arterial Therapies of Non-Colorectal Liver Metastases.
    Puippe G; Pfammatter T; Schaefer N
    Viszeralmedizin; 2015 Dec; 31(6):414-22. PubMed ID: 26889145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radioembolization and chemoembolization for unresectable neuroendocrine liver metastases - a systematic review.
    Yang TX; Chua TC; Morris DL
    Surg Oncol; 2012 Dec; 21(4):299-308. PubMed ID: 22846894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of neuroendocrine tumor liver metastases.
    Lewis MA; Hobday TJ
    Int J Hepatol; 2012; 2012():973946. PubMed ID: 23227348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic artery embolization and chemoembolization for treatment of patients with metastatic carcinoid tumors: the M.D. Anderson experience.
    Gupta S; Yao JC; Ahrar K; Wallace MJ; Morello FA; Madoff DC; Murthy R; Hicks ME; Ajani JA
    Cancer J; 2003; 9(4):261-7. PubMed ID: 12967136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective hepatic artery embolization for treatment of patients with metastatic carcinoid and pancreatic endocrine tumors.
    Strosberg JR; Choi J; Cantor AB; Kvols LK
    Cancer Control; 2006 Jan; 13(1):72-8. PubMed ID: 16508629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GEP-NETS update: Interventional radiology: role in the treatment of liver metastases from GEP-NETs.
    de Baere T; Deschamps F; Tselikas L; Ducreux M; Planchard D; Pearson E; Berdelou A; Leboulleux S; Elias D; Baudin E
    Eur J Endocrinol; 2015 Apr; 172(4):R151-66. PubMed ID: 25385817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review of systemic and liver-directed therapies for metastatic neuroendocrine tumors of the gastroenteropancreatic tract.
    Strosberg JR; Cheema A; Kvols LK
    Cancer Control; 2011 Apr; 18(2):127-37. PubMed ID: 21451455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical treatment of liver metastases in patients with neuroendocrine tumors.
    Saeed A; Buell JF; Kandil E
    Ann Transl Med; 2013 Apr; 1(1):6. PubMed ID: 25332951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multimodal liver-directed management of neuroendocrine hepatic metastases.
    Lewis MA; Hubbard J
    Int J Hepatol; 2011; 2011():452343. PubMed ID: 22121491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Yttrium-90 radioembolization for unresectable metastatic neuroendocrine liver tumor: A systematic review.
    Jia Z; Wang W
    Eur J Radiol; 2018 Mar; 100():23-29. PubMed ID: 29496075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase 1b study of pasireotide, everolimus, and selective internal radioembolization therapy for unresectable neuroendocrine tumors with hepatic metastases.
    Kim HS; Shaib WL; Zhang C; Nagaraju GP; Wu C; Alese OB; Chen Z; Brutcher E; Renfroe M; El-Rayes BF
    Cancer; 2018 May; 124(9):1992-2000. PubMed ID: 29451701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic arterial embolization for the treatment of metastatic neuroendocrine tumors.
    Lee E; Leon Pachter H; Sarpel U
    Int J Hepatol; 2012; 2012():471203. PubMed ID: 22319651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and Efficacy Outcomes of Embolization in Hepatic Sarcomas.
    Pierce DB; Johnson GE; Monroe E; Loggers ET; Jones RL; Pollack SM; Padia SA
    AJR Am J Roentgenol; 2018 Jan; 210(1):175-182. PubMed ID: 29090997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic-directed Therapies in Patients with Neuroendocrine Tumors.
    Kennedy AS
    Hematol Oncol Clin North Am; 2016 Feb; 30(1):193-207. PubMed ID: 26614377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of liver metastases in patients with neuroendocrine tumors: a comprehensive review.
    Harring TR; Nguyen NT; Goss JA; O'Mahony CA
    Int J Hepatol; 2011; 2011():154541. PubMed ID: 22013537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver-directed therapies in liver metastases from neuroendocrine tumors of the gastrointestinal tract.
    Zappa M; Abdel-Rehim M; Hentic O; Vullierme MP; Ruszniewski P; Vilgrain V
    Target Oncol; 2012 Jun; 7(2):107-16. PubMed ID: 22707276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.